Skadden counsels health care and life sciences clients in the areas of transactional, litigation and enforcement, regulatory, finance and intellectual property matters. We represent companies and investors around the globe in every sector of the industry, including pharmaceutical, biotechnology and medical device companies; hospital and health care systems; long-term care facilities; and other service providers. We work with clients on matters of all sizes, from the largest mergers in the industry to smaller, early-stage transactions.

Our attorneys provide our clients with a unique combination of leading transactional capabilities, as well as broad regulatory and litigation experience.

  • We offer a full-range of services, including advising on M&A, corporate restructurings, financings, private equity, complex licensing transactions, product liability defenses, intellectual property matters, regulatory counseling, global and U.S. investigations and enforcement, antitrust matters, securities litigation matters and related legal services.
  • Our global footprint with 22 offices in the Americas, Europe and Asia Pacific allows our attorneys to work seamlessly across our corporate, litigation and regulatory practices to provide service that balances the business prerogatives of our clients with the legal demands on the industry.
  • Our extensive work in health care provides our attorneys with current, sector-specific insights that make our legal advice timely and relevant in the fast-moving health care and life sciences industries.
Our clients have included one-half of the top 40 global pharmaceutical companies and one-quarter of the top 40 global medical device companies (by market capitalization), as well as numerous emerging biotechnology and health care businesses. Some of the largest publicly traded and not-for-profit health care systems are represented by our attorneys. In LMG Life Science’s 2019 rankings, Skadden is cited as a leading firm for both M&A and Products Liability within the life sciences industry. Additionally, we received two Finance and Transactional Deal of the Year awards from LMG Life Sciences in 2018 and recognized among the top firms for Health Care Law by U.S. News — Best Lawyers Best Law Firms 2020. We ranked as a leading firm for Life Sciences by The Legal 500 U.S. 2018 and ranked among general counsel’s top firms for pharmaceutical work BTI Power Rankings 2017. Additionally, we were named The American Lawyer’s 2018 White Collar/Regulatory Litigation Department of the Year and a finalist in New York Law Journal’s 2019 Litigation Department of the Year competition.